These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
474 related articles for article (PubMed ID: 17198719)
1. Toxicokinetic and toxicodynamic analyses of Androctonus australis hector venom in rats: optimization of antivenom therapy. Hammoudi-Triki D; Lefort J; Rougeot C; Robbe-Vincent A; Bon C; Laraba-Djebari F; Choumet V Toxicol Appl Pharmacol; 2007 Feb; 218(3):205-14. PubMed ID: 17198719 [TBL] [Abstract][Full Text] [Related]
2. Combination of two antibody fragments F(ab')(2)/Fab: an alternative for scorpion envenoming treatment. Sami-Merah S; Hammoudi-Triki D; Martin-Eauclaire MF; Laraba-Djebari F Int Immunopharmacol; 2008 Oct; 8(10):1386-94. PubMed ID: 18687300 [TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetic studies of scorpion venom before and after antivenom immunotherapy. Krifi MN; Savin S; Debray M; Bon C; El Ayeb M; Choumet V Toxicon; 2005 Feb; 45(2):187-98. PubMed ID: 15626368 [TBL] [Abstract][Full Text] [Related]
4. Mortality and antibody responses of mice to three successive episodes of experimental scorpion (Centruroides limpidus limpidus) envenomation and immunological rescue. Padilla A; Govezensky T; Possani LD; Larralde C Toxicon; 2005 Aug; 46(2):142-9. PubMed ID: 15946719 [TBL] [Abstract][Full Text] [Related]
5. Effect of antivenom on venom pharmacokinetics in experimentally envenomed rabbits: toward an optimization of antivenom therapy. Rivière G; Choumet V; Audebert F; Sabouraud A; Debray M; Scherrmann JM; Bon C J Pharmacol Exp Ther; 1997 Apr; 281(1):1-8. PubMed ID: 9103473 [TBL] [Abstract][Full Text] [Related]
6. [Application of ELISA for the quantification of Androctonus australis hector venom in the envenomed serum of people and rats before and after immunotherapy]. Hammoudi-Triki D; Laraba-Djebari F Bull Soc Pathol Exot; 2003 Nov; 96(4):297-301. PubMed ID: 14717046 [TBL] [Abstract][Full Text] [Related]
7. Modelling Tityus scorpion venom and antivenom pharmacokinetics. Evidence of active immunoglobulin G's F(ab')2 extrusion mechanism from blood to tissues. Sevcik C; D'Suze G; Díaz P; Salazar V; Hidalgo C; Azpúrua H; Bracho N Toxicon; 2004 Dec; 44(7):731-41. PubMed ID: 15500849 [TBL] [Abstract][Full Text] [Related]
8. Absorption and elimination of viper venom after antivenom administration. Rivière G; Choumet V; Saliou B; Debray M; Bon C J Pharmacol Exp Ther; 1998 May; 285(2):490-5. PubMed ID: 9580588 [TBL] [Abstract][Full Text] [Related]
9. Immunoreactivity and pharmacokinetics of horse anti-scorpion venom F(ab')2-scorpion venom interactions. Pépin-Covatta S; Lutsch C; Grandgeorge M; Lang J; Scherrmann JM Toxicol Appl Pharmacol; 1996 Nov; 141(1):272-7. PubMed ID: 8917700 [TBL] [Abstract][Full Text] [Related]
10. Antivenom for critically ill children with neurotoxicity from scorpion stings. Boyer LV; Theodorou AA; Berg RA; Mallie J; ; Chávez-Méndez A; García-Ubbelohde W; Hardiman S; Alagón A N Engl J Med; 2009 May; 360(20):2090-8. PubMed ID: 19439743 [TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of a F(ab')2 scorpion antivenom administered intramuscularly in healthy human volunteers. Vázquez H; Chávez-Haro A; García-Ubbelohde W; Paniagua-Solís J; Alagón A; Sevcik C Int Immunopharmacol; 2010 Nov; 10(11):1318-24. PubMed ID: 20849955 [TBL] [Abstract][Full Text] [Related]
12. Subacute coagulopathy in a randomized, comparative trial of Fab and F(ab')2 antivenoms. Boyer LV; Chase PB; Degan JA; Figge G; Buelna-Romero A; Luchetti C; Alagón A Toxicon; 2013 Nov; 74():101-8. PubMed ID: 23948058 [TBL] [Abstract][Full Text] [Related]
13. Initial volume of a drug before it reaches the volume of distribution: pharmacokinetics of F(ab')2 antivenoms and other drugs. Sevcik C; Salazar V; Díaz P; D'Suze G Toxicon; 2007 Oct; 50(5):653-65. PubMed ID: 17689580 [TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of a F(ab')2 scorpion antivenom in healthy human volunteers. Vázquez H; Chávez-Haro A; García-Ubbelohde W; Mancilla-Nava R; Paniagua-Solís J; Alagón A; Sevcik C Toxicon; 2005 Dec; 46(7):797-805. PubMed ID: 16197974 [TBL] [Abstract][Full Text] [Related]
15. Comparative study on the ability of IgG and F(ab')2 antivenoms to neutralize lethal and myotoxic effects induced by Micrurus nigrocinctus (coral snake) venom. León G; Stiles B; Alape A; Rojas G; Gutiérrez JM Am J Trop Med Hyg; 1999 Aug; 61(2):266-71. PubMed ID: 10463678 [TBL] [Abstract][Full Text] [Related]
16. Amelioration of cardio-respiratory perturbations following Mesobuthus eupeus envenomation in anesthetized rabbits with commercial polyvalent F(ab')2 antivenom. Zayerzadeh E; Koohi MK; Mirakabadi AZ; Fardipoor A; Kassaian SE; Rabbani S; Anvari MS Toxicon; 2012 Feb; 59(2):249-56. PubMed ID: 22118980 [TBL] [Abstract][Full Text] [Related]
18. Comparison between IgG and F(ab')(2) polyvalent antivenoms: neutralization of systemic effects induced by Bothrops asper venom in mice, extravasation to muscle tissue, and potential for induction of adverse reactions. León G; Monge M; Rojas E; Lomonte B; Gutiérrez JM Toxicon; 2001 Jun; 39(6):793-801. PubMed ID: 11137538 [TBL] [Abstract][Full Text] [Related]
19. [Recombinant antibodies: a new application in scorpion envenomation?]. Muzard J; Billiald P; Goyffon M; Aubrey N Bull Soc Pathol Exot; 2005 Dec; 98(5):383-5. PubMed ID: 16425719 [TBL] [Abstract][Full Text] [Related]
20. The neutralizing capacity of Androctonus crassicauda antivenom against Mesobuthus eupeus scorpion venom. Ozkan O; Carhan A Toxicon; 2008 Aug; 52(2):375-9. PubMed ID: 18625264 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]